GSA Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $947K | Buy |
|
|||||
|
2025
Q1 | $1.05M | Buy |
|
|||||
|
2024
Q4 | $488K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $614K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $564K | Sell |
|
|||||
|
2023
Q2 | $608K | Buy |
|
|||||
|
2023
Q1 | $256K | Sell |
|
|||||
|
2022
Q4 | $470K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.61M | Sell |
|
|||||
|
2022
Q1 | $1.68M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $833K | Buy |
|
|||||
|
2021
Q2 | $209K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $222K | Sell |
|
|||||
|
2018
Q2 | $306K | Sell |
|
|||||
|
2018
Q1 | $303K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $694K | Sell |
|
|||||
|
2016
Q4 | $1.34M | Sell |
|
|||||
|
2016
Q3 | $2.33M | Buy |
|
|||||
|
2016
Q2 | $547K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.94M | Sell |
|
|||||
|
2015
Q3 | $9.72M | Buy |
|
|||||
|
2015
Q2 | $3.55M | Buy |
|
|||||
|
2015
Q1 | $2.23M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $2.55M | Buy |
|
|||||
|
2013
Q4 | $535K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $809K | Buy |
|